PMID: 2107479Apr 1, 1990Paper

Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies

Obstetrics and Gynecology
M H RosoveK C Kalunian

Abstract

Maternal lupus anticoagulants and anticardiolipin antibodies are associated with a syndrome of recurrent pregnancy loss or preterm birth in live-borns, fetal growth retardation, and placental infarction. Fourteen women with one or more abnormal pregnancy outcomes (total 28 losses, one severely growth-retarded premature live-born) and no normal outcomes were treated with full-dose, subcutaneous, twice-daily heparin therapy in subsequent pregnancies. Treatment was started at an estimated gestational age of 10.3 +/- 4.0 (mean +/- SD) weeks (range 6-18), in a mean total daily dosage of 24,700 +/- 7400 units (range 10,000-36,000). Fourteen of 15 pregnancies resulted in live births at 36.1 +/- 1.7 weeks (range 33-39). The mean birth weight percentile was 57 +/- 21 (range 10-90), and Apgar scores were good to excellent. The number of placental infarcts was fewer in treated cases than in previous deliveries. Five fetuses had third-trimester or perinatal problems with no sequelae, four discovered by close maternal-fetal monitoring. There was an increased rate of preterm and cesarean deliveries. Maternal complications of treatment were few and minor, with no hypertension, preeclampsia, or serious drug-related complications. Heparin appea...Continue Reading

Citations

Jun 1, 1994·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·S KonidarisT Mantzavinos
Feb 26, 2000·Fertility and Sterility·R B StrickerE E Winger
Jun 9, 1998·Journal of Reproductive Immunology·D W Branch
Apr 20, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D VinatierJ L Houpeau
Apr 1, 1990·Baillière's Clinical Rheumatology·D J Dudley, D W Branch
Jun 6, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Manjiri Khare, Catherine Nelson-Piercy
Oct 1, 1992·American Journal of Reproductive Immunology : AJRI·A ManyU Martinowitz
Apr 1, 1993·American Journal of Reproductive Immunology : AJRI·I KrauseY Shoenfeld
Mar 1, 1995·American Journal of Reproductive Immunology : AJRI·Y OzakiM Kunimatsu
Jan 1, 1995·American Journal of Reproductive Immunology : AJRI·L D ErmelW H Kutteh
Apr 2, 1999·American Journal of Reproductive Immunology : AJRI·W H KuttehR Silver
Jan 14, 2005·Annals of the Rheumatic Diseases·D Le Thi ThuongJ-C Piette
Dec 1, 1992·Lupus·D A Isenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.